Cyclooxygenase-2 induction and transforming growth factor β growth inhibition in rat intestinal epithelial cells

Cell Growth and Differentiation

Volumn 8, Issue 4, 1997, Pages 463-470

  Sheng, Hongmiao ^a   Shao, Jinyi ^a   Hooton, E Brooke ^a   Tsujii, Masahiko ^a   DuBois, Raymond N ^a,b   Beauchamp, R Daniel ^a,b,c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1; CYCLOOXYGENASE 2; MESSENGER RNA; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; ENZYME INDUCTION; EXPRESSION VECTOR; GROWTH INHIBITION; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN D1; CYCLINS; CYCLOOXYGENASE 2; DNA REPLICATION; DOWN-REGULATION; ENZYME INDUCTION; INTESTINAL MUCOSA; ISOENZYMES; ONCOGENE PROTEINS; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; CYTOMEGALOVIRUS; TRITIUM;

EID: 0030967310     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. 1 Cyclins, Cyclin-Dependent Kinases, and Cyclin Kinase Inhibitors, pp. 43-71. Boston: Birkhauser, 1996.
2. Massague, J., and Polyak, K. Mammalian antiproliferative signals and their targets. Curr. Opin. Genet. Dev., 5: 91-96, 1995.
3. Alexandrow, M. G., and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55: 1452-1457, 1995.
4. Barnard, J. A., Beauchamp, R. D., Coffey, R. J., and Moses, H. L. Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc. Natl. Acad. Sci. USA, 86: 1578-1582, 1989.
5. Kurokowa, M., Lynch, K., and Podolsky, D. K. Effects of growth factors on an intestinal epithelial cell line: transforming growth factor β inhibits proliferation and stimulates differentiation. Biochem. Biophys. Res. Commun., 142: 775-782, 1987.
6. Ciacci, C., Lind, S. E., and Podolsky, D. K. Transforming growth factor β regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology, 105: 93-101, 1993.
7. McGee, D. W., Aicher, W. K., Eldridge, J. H., Peppard, J. V., Mestecky, J., and McGhee, J. R. Transforming growth factor β enhances secretory component and major histocompatibility complex class I antigen expression on rat IEC-6 intestinal epithelial cells. Cytokine, 3: 543-550, 1991.
8. Puolakkainen, P. A., Ranchalis, J. E., Gombotz, W. R., Hoffman, A. S., Mumper, R. J., and Twardzik, D. R. Novel delivery system for inducing quiescence in intestinal stem cells in rats by transforming growth factor β1. Gastroenterology, 107: 1319-1326, 1994.
9. Bronestein, J., and Bull, A. The correlation between 13-hydroxyoctadecadienoate dehydrogenase (13-HODE dehydrogenase) and intestinal cell differentiation. Prostaglandins, 46: 387-395, 1993.
10. Eberhart, C. E., and DuBois, R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology, 109: 285-301, 1995.
11. Tsujii, M., and Dubois, R. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83 (Suppl. 3): 493-501, 1995.
12. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: G393-G400, 1996.
13. Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., and Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/ cyclooxygenase homologue. J. Biol. Chem., 266: 12866-12872, 1991.
14. Simmons, D. L., Levy, D. B., Yannoni, Y., and Erikson, R. L. Identification of a phorbol ester-repressible v-src-inducible gene. Proc. Natl. Acad. Sci. USA, 86: 1178-1182, 1989.
15. Ryseck, R. P., Raynoschek, C., Macdonald-Bravo, H., Dorfman, K., Mattel, M. G., and Bravo, R. Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth & Differ., 3: 443-450, 1992.
16. DuBois, R. N., Tsujii, M., Bishop, P., Awad, J. A., Makita, K., and Lanahan, A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol., 266: G822-G827, 1994.
17. Nathans, D., Lau, L. F., Christy, B., Hartzell, S., Nakabeppu, Y., and Ryder, K. Genomic response to growth factors. Cold Spring Harbor Symp. Quant. Biol., 53: 893-900, 1988.
18. Herschman, H. R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem., 60: 281-319, 1991.
19. Rollins, B. J., and Stiles, C. D. Serum-inducible genes. Adv. Cancer Res., 53: 1-32, 1989.
20. Pines, J. The cell cycle kinases. Semin. Cancer Biol., 5: 305-313, 1994.
21. Sherr, C. J. D-type cyclins. Trends Biochem. Sci., 20: 187-190, 1995.
22. 1. Genes & Dev., 7: 812-821, 1993.
23. 1 phase in rodent fibroblasts. Genes & Dev., 7: 1559-1571, 1993.
24. Ko, T. C., Sheng, H. M., Reisman, D., Thompson, E. A., and Beauchamp, R. D. Transforming growth factor β1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene, 10: 177-184, 1995.
25. 1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56: 733-737, 1996.
26. Reddy, S. T., Gilbert, R. S., Xie, W., Luner, S., and Herschman, H. R. TGF-β1 inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase-2 gene in murine macrophages. J. Leukocyte Biol., 55: 192-200, 1994.
27. Gilbert, R. S., Reddy, S. T., Targan, S., and Herschman, H. R. TGF-β1 augments expression of the TIS10/prostaglandin synthase-2 gene in intestinal epithelial cells. Cell. Mol. Biol. Res., 40: 653-660, 1994.
28. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14: 1669-1679, 1994.
29. Barnard, J. A., Warwick, G. J., and Gold, L. I. Localization of transforming growth factor β isoforms in the normal murine small intestine and colon. Gastroenterology, 105: 67-73, 1993.
30. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNA for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
31. Avery, A., Paraskeva, C., Hall, P., Flanders, K. C., Sporn, M., and Moorghen, M. TGF-β expression in the human colon: differential immunostaining along crypt epithelium. Br. J. Cancer, 68: 137-139, 1993.
32. Chen, R-H., Ebner, R., and Derynck, R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science (Washington DC), 260: 1335-1338, 1993.
33. Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., and Reichmann, E. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes & Dev., 10: 2462-2477, 1996.
34. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
35. Kargman, S., O'Neill, G., Vickers, P., Evans, J., Mancini, J., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
36. Sano, H., Kawahito, Y., Wilder, R., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55 (Suppl. 17): 3785-3789, 1995.
37. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
38. Bartkova, J., Lukas, J., Strauss, M., and Bartek, J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10: 775-778, 1995.
39. Arber, N., Hibshoosh, H., Moss, S. F., Sutter, T., Zhang, Y., Begg, M., Wang, S., Weinstein, I. B., and Holt, P. R. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110: 669-674, 1996.
40. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111: 1134-1140, 1996.
41. Zhang, T., Nanney, L. B., Luongo, C., Lamps, L., Heppner, K. J., DuBois, R. N., and Beauchamp, R. D. Concurrent overexpression of cyclin D1 and cdk4 in intestinal adenomas from Min mice and human familial adenomatous polyposis patients. Cancer Res. 57: 169-175, 1997.
42. Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., and Willett, W. C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121: 241-246, 1994.
43. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333: 609-614, 1995.
44. Thun, M. J., Namboodiri, M. M., and Heath, C. W. J. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
45. Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., and Heath, C. W. J. Aspirin use and risk of fatal cancer. Cancer Res., 53: 1322-1327, 1993.
46. Giardello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
47. Waddell, W. R., and Loughry, R. W. Sulindac for polyposis of the colon. J. Surg. Oncol., 24: 83-87, 1983.
48. Winde, G., Gumbinger, H. G., Osswald, H., Kemper, F., and Bunte, H. The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int. J. Colorectal Dis., 8: 13-17, 1993.
49. Reddy, B. S., Rao, C. V., Rivenson, A., and Kelloff, G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis (Lond.), 14: 1493-1497, 1993.
50. Reddy, B., Tokumo, K., Kulkarni, N., Aligia, C., and Kelloff, G. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis (Lond.), 13 (Suppl. 6): 1019-1023, 1992.
51. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55: 1464-1472, 1995.
52. Min mouse model. Cancer Res., 56: 710-714, 1996.
53. Ko, T. C., Beauchamp, R. D., Townsend, C. M., Jr., Thompson, E. A., and Thompson, J. C. Transforming growth factor β inhibits rat intestinal cell growth by regulating cell cycle-specific gene expression. Am. J. Surg., 167: 14-19, 1994.
54. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.